Dipòsit Digital de Documents de la UAB
Publicación
Artículo científico (JournalArticle)
Clinical consequences of BRCA2 hypomorphism
The tumor suppressor FANCD1/BRCA2 is crucial for DNA homologous recombination repair (HRR). BRCA2 biallelic pathogenic variants result in a severe form of Fanconi anemia (FA) syndrome, whereas monoallelic pathogenic variants cause mainly hereditary breast and ovarian cancer predisposition. For decades, the co-occurrence in trans with a clearly pathogenic variant led to assume that the other allele was benign. However, here we show a patient with biallelic BRCA2 (c.1813dup and c.7796 A.
Proyecto:
Ministerio de Economía y Competitividad CP16/00034
,
Instituto de Salud Carlos III CPII19/00033
,
Ministerio de Economía y Competitividad PI12/02606
,
Ministerio de Economía y Competitividad PI16/01218
,
Instituto de Salud Carlos III PI17/01080
,
Instituto de Salud Carlos III PI19/01303
,
Instituto de Salud Carlos III ACCI-U705/U745-2018
,
European Commission 665919
,
European Commission 305421
,
Ministerio de Sanidad y Consumo CB06/07/0023
,
Agencia Estatal de Investigación RTI2018-098419-B-I00
,
Agència de Gestió d'Ajuts Universitaris i de Recerca 2017/SGR-540